CAMERA: COMBINATION ANTIBIOTIC TREATMENT FOR METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS BACTERAEMIA - A RANDOMISED CONTROLLED TRIAL

Grant number: 1078930 | Funding period: 2015 - 2019

Completed

Abstract

MRSA (golden staph) is resistant to the most useful class of antibiotics: beta-lactams. It is more difficult to treat than antibiotic-sensitive strains. Standard treatment for MRSA is vancomycin but it has high failure rates. Although MRSA is resistant to beta-lactams, lab studies show that they enhance vancomycin’s bacterial killing when used together. CAMERA2 is an RCT comparing vancomycin alone to combination therapy (vancomycin plus flucloxacillin) for adults with MRSA blood stream infection

University of Melbourne Researchers